Current and potential PI3K and BTK inhibitors for CLL
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
Lenalidomide and ibrutinib: do they have a future in treating CLL?
Current and future CLL diagnostic tools
Current research at Weill Cornell and the New York Genome Center